Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 207

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture

Kis, Zoltán, Shattock, Robin, Shah, Nilay, Kontoravdi, Cleo·2019·Biotechnology Journal

Abstract

To stop the spread of future epidemics and meet infant vaccination demands in low‐ and middle‐income countries, flexible, rapid and low‐cost vaccine development and manufacturing technologies are required. Vaccine development platform technologies that can produce a wide range of vaccines are emerging, including: a) humanized, high‐yield yeast recombinant protein vaccines; b) insect cell‐baculovirus ADDomer vaccines; c) Generalized Modules for Membrane Antigens (GMMA) vaccines; d) RNA vaccines. Herein, existing and future platforms are assessed in terms of addressing challenges of scale, cost, and responsiveness. To assess the risk and feasibility of the four emerging platforms, the following six metrics are applied: 1) technology readiness; 2) technological complexity; 3) ease of scale‐up; 4) flexibility for the manufacturing of a wide range of vaccines; 5) thermostability of the vaccine product at tropical ambient temperatures; and 6) speed of response from threat identification to vaccine deployment. The assessment indicated that technologies in the order of increasing feasibility and decreasing risk are the yeast platform, ADDomer platform, followed by RNA and GMMA platforms. The comparative strengths and weaknesses of each technology are discussed in detail, illustrating the associated development and manufacturing needs and priorities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/biot.201800376

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 110

  1. 10.1016/j.vaccine.2017.06.003 · DOI · Paper page
  2. 10.1586/14760584.2013.850035 · DOI
  3. Qadri F., 2012, GAVI Alliance Partner's Forum
  4. 10.1371/journal.pone.0057755 · DOI · Paper page
  5. Wilson P., 2010, Giving Developing Countries the Best Shot: An Overview of Vaccine Access and R & D
  6. Datla M., 2012, GAVI Alliance Partner's Forum
  7. Wen E. P., 2015, Vaccine Development and Manufacturing
  8. 10.1080/14760584.2016.1205492 · DOI
  9. 10.1002/9781118636817 · DOI · Paper page
  10. 10.1155/2015/504831 · DOI
  11. Kallerup R. S., 2015, Subunit Vaccine Deliv, 15, 10.1007/978-1-4939-1417-3_2 · doi:10.1007/978-1-4939-1417-3_2
  12. Bloom B. R., 2016, The Vaccine Book
  13. Meyer H.‐P., 2017, Ind. Biotechnol. Prod. Process
  14. 10.1016/j.biologicals.2014.05.007 · DOI · Paper page
  15. 10.1007/978-1-4615-0053-7 · doi:10.1007/978-1-4615-0053-7
  16. 10.1586/14760584.2015.1067144 · DOI
  17. 10.1080/21645515.2016.1260795 · DOI
  18. 10.1016/S0958-1669(00)00197-X · DOI · Paper page
  19. 10.1002/3527602356.ch12 · doi:10.1002/3527602356.ch12
  20. Yang H., 2015, Pept. Protein Vaccines, 1
  21. 10.3389/fimmu.2018.00884 · DOI
  22. 10.1038/s41598-017-13069-w · DOI
  23. 10.1002/biot.201400427 · DOI
  24. 10.3389/fimmu.2018.00345 · DOI
  25. 10.1002/biot.201600598 · DOI
  26. 10.1002/biot.201700443 · DOI
  27. 10.1002/biot.201700749 · doi:10.1002/biot.201700749
  28. 10.1038/298347a0 · DOI · Paper page
  29. 10.1093/jnci/djj144 · DOI
  30. Kirnbauer R., 1993, J. Virol, 67, 6929, 10.1128/jvi.67.12.6929-6936.1993 · DOI
  31. 10.4161/hv.6.5.11023 · DOI
  32. 10.1016/j.vaccine.2016.10.016 · DOI
  33. 10.3389/fimmu.2014.00121 · DOI · Paper page
  34. 10.4161/hv.24129 · DOI · Paper page
  35. 10.1179/2047773214Y.0000000162 · DOI
  36. 10.1128/JVI.75.9.4040-4047.2001 · DOI · Paper page
  37. 10.3390/vaccines2040785 · doi:10.3390/vaccines2040785
  38. 10.2174/1872215611307010009 · doi:10.2174/1872215611307010009
  39. 10.1002/vms3.65 · doi:10.1002/vms3.65
  40. 10.1016/j.vaccine.2008.11.045 · doi:10.1016/j.vaccine.2008.11.045
  41. 10.1128/AEM.02817-12 · DOI
  42. 10.1038/nrmicro1087 · DOI · Paper page
  43. 10.1093/bfgp/elv041 · DOI
  44. 10.1007/s10529 · doi:10.1007/s10529
  45. 10.1371/journal.pone.0037915 · DOI
  46. 10.1371/journal.pone.0075347 · DOI
  47. 10.4161/bioe.22856 · DOI · Paper page
  48. 10.1038/nprot.2008.213 · DOI · Paper page
  49. 10.1016/j.jbiotec.2008.12.015 · DOI · Paper page
  50. 10.1016/j.pep.2004.03.019 · doi:10.1016/j.pep.2004.03.019
  51. 10.1016/j.copbio.2007.09.001 · DOI · Paper page
  52. 10.1016/0264-410X(90)90221-7 · DOI
  53. 10.1016/0168-1656(91)90264-V · doi:10.1016/0168-1656(91)90264-v
  54. 10.1038/nmeth983 · DOI · Paper page
  55. Berger I., 2013, J. Vis. Exp, 50159
  56. 10.1016/j.vaccine.2012.01.016 · DOI · Paper page
  57. 10.1016/j.vaccine.2014.07.074 · DOI
  58. 10.1073/pnas.1705836114 · DOI
  59. 10.1128/JVI.67.8.4566-4579.1993 · DOI · Paper page
  60. 10.1080/21655979.2015.1104433 · doi:10.1080/21655979.2015.1104433
  61. Sari D., 2016, Adv. Exp. Med. Biol, 199
  62. C. Geisler H. Mabashi‐Asazuma D. L. Jarvis A. Castilho 2015 Springer New York New York NY 131 · DOI
  63. 10.4161/bioe.22327 · doi:10.4161/bioe.22327
  64. 10.1371/journal.pone.0034226 · DOI
  65. D. Sari K. Gupta D. B. T. G. Raj A. Aubert P. Drncová F. Garzoni D. Fitzgerald I. Berger M. C. Vega 2016 Springer International Publishing Cham 199 · DOI
  66. 10.1038/nbt1036 · DOI · Paper page
  67. 10.1128/JVI.07127-11 · doi:10.1128/jvi.07127-11
  68. 10.1073/pnas.72.1.93 · DOI · Paper page
  69. 10.1128/JVI.76.17.8682-8689.2002 · DOI
  70. Kulp A., 2012, Annu Rev Microbiol, 163
  71. 10.1002/biot.201400395 · DOI · Paper page
  72. 10.1002/pmic.200900338 · DOI · Paper page
  73. 10.1073/pnas.1008843107 · DOI · Paper page
  74. 10.1172/JCI44261 · DOI · Paper page
  75. 10.1007/s00792-008-0199-x · DOI · Paper page
  76. 10.1371/journal.pone.0134353 · DOI
  77. 10.1371/journal.pone.0134478 · DOI · Paper page
  78. 10.1016/j.micres.2014.09.006 · DOI · Paper page
  79. 10.1073/pnas.0805532107 · DOI · Paper page
  80. 10.1016/j.vaccine.2014.03.068 · DOI
  81. 10.1016/j.vaccine.2010.04.082 · DOI · Paper page
  82. 10.1371/journal.pone.0065157 · doi:10.1371/journal.pone.0065157
  83. 10.1021/pr301208g · DOI
  84. 10.1016/j.smim.2013.05.004 · DOI
  85. 10.1074/jbc.M114.566570 · DOI
  86. 10.1016/j.jbiotec.2015.01.020 · doi:10.1016/j.jbiotec.2015.01.020
  87. 10.1016/j.vaccine.2016.11.089 · DOI
  88. 10.1371/journal.pone.0035616 · DOI
  89. N. Pardi H. Muramatsu D. Weissman K. Karikó P. M. Rabinovich 2013 Humana Press Totowa NJ 29 · DOI · Paper page
  90. 10.1016/j.ymthe.2017.03.023 · DOI · Paper page
  91. 10.1016/j.omtn.2017.06.005 · DOI · Paper page
  92. 10.14304/SURYA.JPR.V4N7.5 · DOI · Paper page
  93. 10.1016/S0264-410X(99)00271-6 · DOI · Paper page
  94. 10.3390/vaccines1030225 · DOI · Paper page
  95. 10.1016/j.ymthe.2017.11.017 · DOI · Paper page
  96. 10.1586/14760584.2015.965690 · DOI
  97. 10.1517/17425247.2014.901308 · DOI · Paper page
  98. 10.1016/j.nano.2015.11.001 · DOI
  99. 10.1016/j.jconrel.2017.09.018 · DOI
  100. 10.1155/2015/794528 · DOI · Paper page
  101. 10.1093/nar/gkn342 · DOI · Paper page
  102. Brito L. A., 2015, Nonviral Vectors Gene Ther, 179
  103. 10.1093/nar/gkw551 · DOI · Paper page
  104. Nigel A., 2013, J. Chem. Technol. Biotechnol, 89, 1283
  105. 10.1016/j.csbj.2016.06.007 · DOI
  106. 10.1099/jmm.0.039180-0 · DOI
  107. 10.1371/journal.pone.0111827 · DOI
  108. 10.1039/C4CC05086J · DOI
  109. World Health Organization inImmun. Pract. A Pract. Guid. Heal. Staff − 2015 Updat. Non‐Serial Publ. World Health Organization ISBN: 9241549092 9789241549097 2015 pp.1.
  110. 10.1016/j.vaccine.2016.11.097 · DOI

Cited by

See all 207

Metadata

Authors
Kis, Z., Shattock, R., Shah, N., & Kontoravdi, C.
Venue
Biotechnology Journal
Publisher
Wiley
Published
2018-12-10
Volume
14
Issue
1
Pages
1-2
ISSN
  • 1860-6768 (ISSN-L)
  • 1860-7314
OpenAlex
W2903668992
Cited by
207
References
6
FWCI
9.34
Type
journal article
Language
en
Open access
closed
Funders
Engineering and Physical Sciences Research Council (EP/R013764/1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture. https://app.cochat.ai/papers/10.1002/biot.201800376
The paper
Kis, Z., Shattock, R., Shah, N., & Kontoravdi, C. (2019). Emerging Technologies for Low‐Cost, Rapid Vaccine Manufacture. Biotechnology Journal. https://doi.org/10.1002/biot.201800376

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.